All Type of News
Pharmacists, drugmakers square off over small drug packet
The conflict is deepening between pharmacists and pharmaceutical companies.
The Korea Pharmaceutical Association is still holding to its position that the current small drug packet system should be promoted through...
GSK promotes local clinical trials in Korea
GlaxoSmithKline plc has boosted its intensive clinical studies in Korea by focusing on three core therapeutic fields, such as oncology, neuroscience and respiratory disease, according to its Korea unit.
GSK Korea c...
Pharmacists support bill to refund hospital’s overcharging money
A bill to help patients get their money refunded over the treatment costs overcharged by hospitals is feasible, according to the Korea Pharmaceutical Association.
The KPA vice chairman Lee Hyung-chul said in a rece...
Medication costs top 2.5 trillion won in first quarter
The national health insurance spent 9.1 trillion won in the first half of this year to cover medication costs for its subscribers, equivalent to some 27.2 percent of its total expenditure. It spent about 8.4 trillion ...
Validation system for OTC product due next month
The obligatory validation system for OTC products is to be implemented from next month, according to the Korea Food and Drug Administration.
Under the new good manufacturing practice (GMP) rules, OTC makers, who in...
KFDA mulls incentive over tar pigment-free cold medicines
The Korea Food and Drug Administration is to ask pharmaceutical firms to boost the production of tar pigment-free cold medicines for children.
To this end, the drug agency is also considering shortening its product...
KFDA approves Xenical generics
Many women and men struggle with their weight. Experts say diet and exercise are important parts of achieving your weight loss goals, but for those who are very overweight or even obese, this may not be enough.
Th...
Drugmakers in race for orlistat market
Domestic drug makers are expected to be vying for a bigger share of the growing market for orlistat.
The domestic orlistat market size is estimated at 15 billion won.
Boram Pharm announced an ambitious target fo...
Increased coverage for rare or intractable diseases
Those patients who would fulfill their registration procedure as rare or intractable diseases from June 1 to September 30 this year can benefit from increasing coverage, the Ministry of Health, Welfare and Family Affa...
Domestic wholesalers to go all-out against Samsung Moonsan
With Samsung Mulsan’s intention to advance into the local drug logistics business through Care Camp, the Korea Association of Pharmaceutical Wholesaler has united its whole strength to deter Samsung’s scheme.
The a...
